ProCE Banner Activity

CE / CME

Managing COVID-19 Risk in Individuals With Metabolic Syndrome and Obesity

Video

In this 1-hour webinar, learn from expert faculty as they review key data and strategies to reduce the risk of severe COVID-19 and long COVID in patients with obesity and metabolic syndrome.

Nurses: 1.00 Nursing contact hour

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit

Released: September 19, 2023

Expiration: September 18, 2024

No longer available for credit.

Share

Faculty

Rasika Karnik

Rasika Karnik, MS, MD

Assistant Professor
Division of Primary Care, Department of Internal Medicine
University of Chicago
Medical Director
Post-Covid Recovery Clinic
Chicago, Illinois

Donna H Ryan

Donna H Ryan, MD

Professor Emerita
Pennington Biomedical Research Center
LSU
Baton Rouge, Louisiana

Renslow Sherer

Renslow Sherer, MD

Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange

ProCE Banner
ProCE Banner

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer, Inc.

Target Audience

The primary target audiences for this educational activity include internal medicine/family medicine/primary care providers (MDs, NPs, PAs), endocrinologists, cardiologists, and other HCPs who manage people with obesity/metabolic syndrome who are at risk for severe acute and long-term complications from COVID-19.

Program Learning Goal

The goal of this activity is to improve HCPs’ awareness of the risk of acute and long-term complications of COVID-19 in people with obesity and/or metabolic syndrome and to increase HCPs’ competence in appropriate management and prevention of acute and long COVID-19 in this population.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Counsel people with obesity and/or metabolic syndrome on the risks associated with severe acute and postacute COVID-19 outcomes 

  • Select the most appropriate prevention and treatment strategies for COVID-19 in ambulatory patients with obesity and/or metabolic syndrome

  • Incorporate strategies aimed at reducing the impact of healthcare disparities in the prevention and treatment of people with obesity/metabolic syndrome and COVID-19

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Rasika Karnik, MS, MD

Assistant Professor
Division of Primary Care, Department of Internal Medicine
University of Chicago
Medical Director
Post-Covid Recovery Clinic
Chicago, Illinois

Rasika Karnik, MS, MD: consultant/advisor/speaker: Gilead Sciences.

Donna H Ryan, MD

Professor Emerita
Pennington Biomedical Research Center
LSU
Baton Rouge, Louisiana

Donna Ryan, MD: advisor: Altimmune, Amgen, Biohaven, Boeringer Ingelheim, Calibrate, Carmot, Epitomee, Gila Therapeutics, Lilly, Novo Nordisk, Scientific Intake, Structure Tx, Xeno, YSOPIA, Zealand; speaker: IFA Celtic, Novo Nordisk, Lilly; individual publicly traded stock/stock options: Epitomee, Calibrate, Ro, Scientific Intake, Xeno; clinical trial: Novo Nordisk; data safety monitoring board: IQVIA (Rhythm), Lilly.

Renslow Sherer, MD

Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Renslow Sherer, MD: researcher: Gilead.

The planners and content peer reviewers from Clinical Care Options, LLC and Practicing Clinicians Exchange do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from September 19, 2023, through September 18, 2024:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hour awarded for this Nursing Continuing Professional Development activity is 1 contact hour.